Both in Biotechnology
CRISPR Therapeutics AG vs Scholar Rock Holding
Over the past year CRSP returned −14.6% and SRRK returned +29.8%; their daily moves had a correlation of 0.26.
CRSP −14.6% SRRK +29.8%Growth of $1, one year, split-adjusted
| Metric | CRSP | SRRK |
|---|---|---|
| Price | $55.32 | $48.32 |
| Market cap | $5.35B | $5.88B |
| Today | −1.21% | +1.19% |
| 1 month | −2.9% | −14.9% |
| 6 months | +16.3% | −1.7% |
| Year to date | +5.5% | +9.7% |
| 1 year | −13.3% | +26.0% |
| Revenue growth (YoY) | +1041.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −895.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 399.4× | — |
| Net cash | $1.78B | $295.9M |
| Dividend yield | — | — |
| Volatility (60d) | 52.3% | 48.1% |
| Short % of float | 23.1% | 18.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).